Bio Green Med Solution, Inc.
corporate_fare Company Profile
Bio Green Med Solution, Inc. (NASDAQ:BGMS) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 17 items for BGMS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-09, rated 9/10. Across its 17 most recent items scored 7 or higher, the top rating is 10/10, with 12 rated 8 or above. Recent SEC coverage for BGMS spans 424B3, S-4/A, 10-Q, S-4.
Recent high-impact activity:
- BGMS Mails Definitive Proxy for $2B Reverse Merger with Future NRG — Vote Set for Nov 19
- BGMS Sets Nov 19 Vote on $2B Reverse Merger; Existing Holders Face >99% Dilution
- Bio Green Med Solution Q2 Loss Narrows, But Going Concern Doubts and a $12M Lawsuit Loom
- Bio Green Med Solution Q2 Loss Narrows to $0.4M, Cash Runway Extended to Q1 2027
- BGMS Files S-4 for Reverse Merger: Existing Shareholders to Own Less Than 1% of Combined Entity Valued at $2 Billion
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 30,190 shares in BGMS as of the October 15, 2026 settlement, a 440.0% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 2, 2026, 29.7% of BGMS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for BGMS, detected from its recent SEC filings · based on capital-structure filings through 2026-10-09.
Definitive Proxy Mailed for $2B Reverse Merger · Existing Stockholders Diluted to Under 1%
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →